Skip NavigationSkip to Content

6-alkylamino- and 2,3-dihydro-3 '-methoxy-2-phenyl-4- quinazolinones and related compounds: Their synthesis, cytotoxicity, and inhibition of tubulin polymerization

  1. Author:
    Hour, M. J.
    Huang, L. J.
    Kuo, S. C.
    Xia, Y.
    Bastow, K.
    Nakanishi, Y.
    Hamel, E.
    Lee, K. H.
  2. Author Address

    China Med Coll, Grad Inst Pharmaceut Chem, Taichung, Taiwan. China Med Coll, Grad Inst Pharmaceut Chem, Taichung, Taiwan. Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA. NCI, Frederick Canc Res & Dev Ctr, Div Canc Treatment & Diag, Dev Therapeut Program, Screening Technol Branch, Frederick, MD 21702 USA.
    1. Year: 2000
  1. Journal: Journal of Medicinal Chemistry
    1. 43
    2. 23
    3. Pages: 4479-4487
  2. Type of Article: Article
  1. Abstract:

    As part of our continuing search for potential anticancer candidates among 2-phenyl-4-quinolones and 2-phenyl-4- quinazolinones, two series of 6,7,2',3',4',5'-substituted 2- phenyl-4-quinazolinones and 6,2',3',4',5'-substituted 2,3- dihydro-2-phenyl-4-quinazolinones were synthesized and evaluated for cytotoxicity and as inhibitors of tubulin polymerization. In general, a good correlation was found between the two activities. Five of the 6-substituted heterocyclic 2-phenyl-4-quinozolinones (37-51) showed significant cytotoxicity against a panel of human tumor cell lines with EC50 values in the low micromolar to nanomolar concentration ranges. Compound 38 was the most potent of these compounds, as well as the most potent inhibitor of tubulin polymerization in this series. The activity of 38 was in the same range as those of the antimitotic natural products, colchicine, podophyllotoxin, and combretastatin A-4. Substituted 2-phenyl-4-quinazolinones and 2,3-dihydro-2-phenyl- 4-quinazolinones also displayed highly selective cytotoxicity against the ovarian cancer 1A9 and P-gp resistant KB-VIN cell lines.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel